Hartline Investment Corp Novo Nordisk A S Transaction History

Hartline Investment Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$122.71 - $146.91 $1.93 Million - $2.31 Million	-15,754 Reduced 90.68%	1,620 $231,000
Q1 2024 Apr 30, 2024	BUY	$102.11 - $135.92 $1.77 Million - $2.36 Million	17,374 New	17,374 $2.23 Million
Q2 2018 Aug 10, 2018	SELL	$44.29 - $50.42 $3.08 Million - $3.51 Million	-69,622 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$48.49 - $58.14 $383,555 - $459,887	-7,910 Reduced 10.2%	69,622 $3.43 Million
Q4 2017 Feb 13, 2018	SELL	$47.53 - $53.73 $134,272 - $151,787	-2,825 Reduced 3.52%	77,532 $4.16 Million
Q3 2017 Nov 20, 2017	BUY	$41.15 - $49.22 $3.31 Million - $3.96 Million	80,357	80,357 $3.87 Million

1,928

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $178B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Hartline Investment Corp, based on Form 13F filings with the SEC.

Stay updated on Hartline Investment Corp with notifications on news.